Latest Articles

Publication Date
Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial - The Clinical Trial Vanguard

Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial The Clinical Trial Vanguard

Published: Aug. 1, 2026, 6:33 a.m.
Reliability and validity of the 30-second chair-stand test for assessing functional capacity in women with endometriosis: a cross-sectional and longitudinal study.

and Hypothesis: Endometriosis often causes pelvic pain, limiting movement and physical function. Performance-based tests are fundamental to measure functional status among these women. This study aimed to evaluate the reliability …

Published: Aug. 1, 2026, midnight
Expression Profiling of Immune-Related Genes in Different Samples from Patients with Endometriosis Revealed Upregulation of THBS1, CHGB and CYR61.

Endometriosis is a chronic, inflammatory, estrogen-dependent disease that affects approximately 6-10% of women of reproductive age. The present study aimed to investigate the expression of 48 immune-related genes in different …

Published: Aug. 1, 2026, midnight
'I lost years waiting for endometriosis diagnosis' - AOL.com

'I lost years waiting for endometriosis diagnosis' AOL.com

Published: July 31, 2026, 11:18 p.m.
Karyopharm To Stick With Blood Cancers As Xpovio Flops In Endometrial Cancer - insights.citeline.com

Karyopharm To Stick With Blood Cancers As Xpovio Flops In Endometrial Cancer insights.citeline.com

Published: July 31, 2026, 8:31 p.m.
Selinexor Maintenance Misses Mark in TP53 Wild-Type Endometrial Cancer - Targeted Oncology

Selinexor Maintenance Misses Mark in TP53 Wild-Type Endometrial Cancer Targeted Oncology

Published: July 31, 2026, 8:06 p.m.
Real-World Study Supports Multi-Omic Blood Test for Endometriosis - Clinical Lab Products

Real-World Study Supports Multi-Omic Blood Test for Endometriosis Clinical Lab Products

Published: July 31, 2026, 7:35 p.m.
Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - OncLive

Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer OncLive

Published: July 31, 2026, 5:22 p.m.
Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - onclive.com

Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer onclive.com

Published: July 31, 2026, 5:22 p.m.
5 Fun Things To Do In Aruba With Kids Endometriosis (hcxsIUHUaD) - Mshale

5 Fun Things To Do In Aruba With Kids Endometriosis (hcxsIUHUaD) Mshale

Published: July 31, 2026, 5:20 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!